Finanzwire Finanzwire
Basculer en Français
11259 Companies
250096 Keywords
178541 Articles
135995 Press releases
Headlines Articles Press releases CAGE Bio Inc. Remove
  1. Home
  2. Companies
  3. CAGE Bio Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/09/2025 at 21:05, 1 year 9 months ago

    CAGE Bio Launches Phase 2b Trial for Atopic Dermatitis Treatment CGB-500

    Phase 2B Trial Atopic Dermatitis CAGE Bio CGB-500 Ionic Liquid Technology
  • PRESS RELEASE

    published on 01/09/2025 at 21:00, 1 year 9 months ago

    CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis

    CAGE Bio initiates Phase 2b trial for CGB-500, a topical JAK inhibitor ointment for atopic dermatitis. High efficacy, low side-effects. Improving patient outcomes
    Phase 2B Trial Atopic Dermatitis CAGE Bio CGB-500 Topical Therapy
    Logo of CAGE Bio Inc.
  • PRESS RELEASE

    published on 08/03/2023 at 16:45, 3 years 2 months ago

    CAGE Bio Announces Positive Topline Results From its Double-Blind Phase 2 Study Evaluating an Ionic Liquid formulation of 1% Tofacitinib In Patients with Atopic Dermatitis

    Logo of CAGE Bio Inc.
Accesswire
  • Published on 11/02/2026 at 23:15, 5 hours 24 minutes ago

    ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations

  • Published on 11/02/2026 at 22:30, 6 hours 9 minutes ago

    Sparton Files Morrison Mine N-I 43-101 Technical Report

  • Published on 11/02/2026 at 17:00, 11 hours 39 minutes ago

    PPX Mining Initiates Operating Permit Process for Igor Processing Plant

  • Published on 11/02/2026 at 17:00, 11 hours 39 minutes ago

    QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems

  • Published on 11/02/2026 at 16:15, 12 hours 24 minutes ago

    ACCESS Newswire Launches SPOT, Seven AI Agents That Check Every Press Release Before Submission

View all ACCESSWIRE
EQS Group
  • Published on 11/03/2026 at 03:30, 1 hour 9 minutes ago

    ADTRAN Holdings, Inc. reports third quarter 2026 financial results

  • Published on 11/03/2026 at 03:25, 1 hour 14 minutes ago

    How President Xi Jinping Has Charted the Course for Boosting China's Strength in Finance: Pursuing a Path of Financial Development with Chinese Characteristics

  • Published on 11/03/2026 at 02:55, 1 hour 44 minutes ago

    WESCAN GOLDFIELDS ANNOUNCES ENGAGEMENT OF RED CLOUD SECURITIES FOR LIQUIDITY SERVICES

  • Published on 11/02/2026 at 23:11, 5 hours 28 minutes ago

    EQS-Adhoc: HUGO BOSS AG: HUGO BOSS UPDATES ITS FULL YEAR 2026 OUTLOOK

  • Published on 11/02/2026 at 22:05, 6 hours 34 minutes ago

    Abivax to Participate in Upcoming Fall Investor Conferences

View all EQS
Les Echos
  • Published on 11/02/2026 at 21:08, 7 hours 31 minutes ago

    GROUPE SFPI LIQUIDIDY CONTRAT H1 2026

  • Published on 11/02/2026 at 18:30, 10 hours 9 minutes ago

    Disclosure of transactions in own shares from October 26 to October 30, 2026

  • Published on 11/02/2026 at 18:17, 10 hours 22 minutes ago

    Reporting on share buyback transactions carried out between October 28 and October 29, 2026

  • Published on 11/02/2026 at 18:00, 10 hours 39 minutes ago

    Covivio - Information on total number of voting rights and share capital

  • Published on 11/02/2026 at 17:59, 10 hours 40 minutes ago

    Saint-Gobain completes the divestment of its Dahl specialist distribution business in Sweden, Norway and Denmark

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy